QTREX Quantum (QTEX) Stock Price, News & Analysis

Company Overview

Inspira Technologies OXY B.H.N. Ltd. is a medical technology company focused on developing advanced respiratory-support and blood-monitoring solutions for critical-care settings. The company’s technologies are intended to help address complications associated with respiratory failure and improve the management of patients requiring oxygenation support.

Its product portfolio includes the INSPIRA ART system, an extracorporeal respiratory-support platform designed to provide oxygenation while potentially reducing the need for conventional mechanical ventilation or more complex extracorporeal membrane oxygenation procedures. The company is also developing the HYLA blood-sensor technology, which is intended to provide continuous monitoring of blood parameters during treatment.

Inspira Technologies is based in Israel and serves the global medical-device market through the development of products for hospitals and intensive-care environments. The company was founded by Dagi Ben-Noon, who serves as its chief executive officer. Its technologies remain subject to applicable regulatory and clinical-development requirements in the markets where the company seeks commercialization.

Key Stats

• Today's Range: $1.14 to $1.26
• 50-Day Range: $0.68 to $1.87
• 52-Week Range: $0.28 to $3.85
• Volume: 4.11 million shs
• Average Volume: 11.63 million shs
• Market Capitalization: $44.07 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

QTREX Quantum Stock Analysis - MarketRank™

QTREX Quantum scored higher than 33% of companies evaluated by MarketBeat, and ranked 740th out of 892 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

QTREX Quantum has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

QTREX Quantum has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

QTREX Quantum has a P/B Ratio of 19.92. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

14.10% of the float of QTREX Quantum has been sold short.

Short Interest Ratio / Days to Cover

QTREX Quantum has a short interest ratio ("days to cover") of 0.69, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in QTREX Quantum has recently decreased by 16.86%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

QTREX Quantum does not currently pay a dividend.

Dividend Growth

QTREX Quantum does not have a long track record of dividend growth.

News and Social Media

• Score: 3.9 / 5
• News Sentiment: 1.27

News Sentiment

QTREX Quantum has a news sentiment score of 1.27. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for QTREX Quantum this week, compared to 1 article on an average week.

Search Interest

Only 2 people have searched for QTEX on MarketBeat in the last 30 days. This is a decrease of -88% compared to the previous 30 days.

MarketBeat Follows

2 people have added QTREX Quantum to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 4.4 / 5
• Insider Trading: Acquiring Shares

Cluster Insider Buying

2 insiders have purchased shares of QTREX Quantum in the last three months. Multiple insiders buying is a strong bullish signal.

Net Insider Buying

Over the last three months, insiders have purchased a net $181,275.00 in company stock, which represents 0.4220% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, QTREX Quantum insiders have bought more of their company's stock than they have sold. Specifically, they have bought $181,275.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

29.40% of the stock of QTREX Quantum is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

12.72% of the stock of QTREX Quantum is held by institutions.

Company Calendar

• Last Earnings: 9/24/2026
• Today: 11/13/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:QTEX
• Previous Symbol: NASDAQ:QTEXW
• CIK: 1837493
• Web: q-trex.com
• Phone: 972-9-9664488
• Fax: N/A
• Employees: 41
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.12
• Current Ratio: 2.00
• Quick Ratio: 1.62

Sales & Book Value

• Annual Sales: $290 thousand
• Price / Sales: 153.10
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.06 per share
• Price / Book: 20.58

Miscellaneous

• Outstanding Shares: 35,950,000
• Free Float: 25,380,000
• Market Cap: $44.40 million
• Optionable: N/A
• Beta: 3.97